Korean J Urol. 2010 Aug;51(8):511-7. doi: 10.4111/kju.2010.51.8.511. Epub 2010 Aug 18.
Bone morphogenetic protein signaling: implications in urology.
Korean journal of urology
Jeongyun Jeong, Dong Il Kang, Geun Taek Lee, Isaac Yi Kim
Affiliations
Affiliations
- Department of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
PMID: 20733955
PMCID: PMC2924553 DOI: 10.4111/kju.2010.51.8.511
Abstract
The bone morphogenetic proteins (BMPs), as members of the transforming growth factor-beta (TGF-beta) superfamily, not only control bone formation, but also regulate multiple key steps during embryonic development and differentiation. Furthermore, BMPs play critical roles in maintaining the homeostasis of the cardiovascular, pulmonary, reproductive, urogenital, and nervous systems in adult life. Like all members of the TGF-beta superfamily, BMP signaling is mediated through a heteromeric complex of type I and type II transmembrane serine/threonine kinase receptors. The subsequent signal transduction cascade includes either the canonical Smad-dependent or non-canonical Smad-independent pathways. Reflecting the critical function of BMPs, BMP signaling is tightly regulated at multiple steps by various mechanisms including extracellular endogenous antagonists, neutralizing antibodies/extracellular soluble receptor domains, small molecule inhibitors, cytoplasmic inhibitory Smads, and transcriptional co-repressors. Recently, dorsomorphin, the first small molecule inhibitor of BMP signaling, was identified and suggested as a useful tool for dissecting the mechanisms of signaling pathways and for developing novel therapeutics for diverse human diseases that are related to the BMP signaling pathways. In this article, we discuss various mechanisms involved in regulating BMP signaling pathways and their implications for urology.
Keywords: Bone morphogenetic proteins; Dorsomorphin; Signal transduction; Transforming growth factors
References
- Dev Biol. 2002 Oct 15;250(2):231-50 - PubMed
- Prostate. 2004 Apr 1;59(1):101-6 - PubMed
- Dev Biol. 2001 Dec 15;240(2):457-73 - PubMed
- J Cell Physiol. 2001 Jun;187(3):265-76 - PubMed
- Nature. 1999 Aug 12;400(6745):687-93 - PubMed
- Br J Cancer. 2005 Oct 17;93(8):949-52 - PubMed
- Science. 2004 Mar 12;303(5664):1684-6 - PubMed
- Cancer Res. 1997 Oct 1;57(19):4427-31 - PubMed
- Neoplasia. 2005 May;7(5):509-21 - PubMed
- Science. 1988 Dec 16;242(4885):1528-34 - PubMed
- Carcinogenesis. 2007 Jun;28(6):1153-62 - PubMed
- Nat Genet. 2003 Jul;34(3):303-7 - PubMed
- Cell. 1996 Aug 23;86(4):599-606 - PubMed
- J Bone Miner Res. 2002 Feb;17(2):293-300 - PubMed
- Nat Chem Biol. 2008 Jan;4(1):33-41 - PubMed
- Genes Dev. 1998 Jan 15;12(2):186-97 - PubMed
- J Biol Chem. 1997 Apr 25;272(17):11535-40 - PubMed
- J Cell Sci. 2000 Apr;113 ( Pt 7):1101-9 - PubMed
- J Urol. 2008 Dec;180(6):2660-7 - PubMed
- Growth Factors. 2004 Dec;22(4):233-41 - PubMed
- Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7632-6 - PubMed
- Dev Biol. 1998 May 15;197(2):205-17 - PubMed
- Cancer Metastasis Rev. 2005 Jun;24(2):251-63 - PubMed
- Nat Rev Cancer. 2008 Oct;8(10):806-12 - PubMed
- Nature. 2008 Aug 21;454(7207):1000-4 - PubMed
- Int J Dev Biol. 1999;43(5):405-11 - PubMed
- Mol Cell. 1998 Apr;1(5):673-83 - PubMed
- Science. 1994 Apr 1;264(5155):101-4 - PubMed
- Development. 2000 Feb;127(4):821-30 - PubMed
- Dev Dyn. 1997 Mar;208(3):349-62 - PubMed
- Mol Biol Cell. 2008 Feb;19(2):457-64 - PubMed
- Cell Signal. 2004 Mar;16(3):291-9 - PubMed
- Mod Pathol. 2008 Dec;21(12):1436-43 - PubMed
- Kidney Blood Press Res. 2009;32(6):445-50 - PubMed
- Br J Cancer. 1992 Dec;66(6):1159-63 - PubMed
- Cancer Res. 2004 Nov 15;64(22):8276-84 - PubMed
- Cell. 2007 Oct 19;131(2):242-56 - PubMed
- Am J Pathol. 2007 Sep;171(3):1047-57 - PubMed
- Front Biosci. 2008 May 01;13:4726-39 - PubMed
- J Bone Miner Res. 2008 Mar;23(3):305-13 - PubMed
- Cell. 1999 Sep 3;98(5):573-83 - PubMed
- Bone. 2006 Jul;39(1):61-71 - PubMed
- Cancer Res. 2004 Oct 15;64(20):7355-60 - PubMed
- Development. 2004 Jul;131(14):3401-10 - PubMed
- Endocr Rev. 2003 Apr;24(2):218-35 - PubMed
- Mol Endocrinol. 2008 Dec;22(12):2689-702 - PubMed
- J Mol Histol. 2009 Oct;40(5-6):331-41 - PubMed
- FASEB J. 2007 Jan;21(1):256-64 - PubMed
- J Bone Joint Surg Am. 2003;85-A Suppl 3:44-51 - PubMed
- J Biol Chem. 2005 Jul 1;280(26):24443-50 - PubMed
- Nature. 1999 Feb 25;397(6721):707-10 - PubMed
- Biochem Biophys Res Commun. 1999 Jun 24;260(1):240-4 - PubMed
- J Biol Chem. 2002 Feb 15;277(7):5330-8 - PubMed
- Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11740-4 - PubMed
- Mol Pharmacol. 2002 Jul;62(1):65-74 - PubMed
- Cell. 1998 Dec 11;95(6):737-40 - PubMed
- J Cell Biol. 2001 Dec 10;155(6):1017-27 - PubMed
- FEBS Lett. 2003 Jul 3;546(1):133-9 - PubMed
- Annu Rev Biochem. 1998;67:753-91 - PubMed
- Prostate. 2003 Mar 1;54(4):268-74 - PubMed
- Osteoarthritis Cartilage. 2009 Feb;17(2):263-70 - PubMed
- PLoS One. 2008 Aug 06;3(8):e2904 - PubMed
- J Cell Biol. 1995 Jul;130(1):217-26 - PubMed
- Biol Chem. 2004 Aug;385(8):697-710 - PubMed
- Int J Dev Biol. 2000 Apr;44(3):253-65 - PubMed
- Genesis. 2003 Jan;35(1):43-56 - PubMed
- Cancer Res. 2000 Jun 1;60(11):2840-4 - PubMed
- Genes Dev. 1995 Nov 15;9(22):2795-807 - PubMed
- Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6046-51 - PubMed
Publication Types